Initiation and regulation of tissue factor-dependent blood coagulation.

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Arteriosclerosis and Thrombosis A Journal of Vascular Biology

• Publication date

  1992-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1161/01.ATV.12.10.1111PMID 1390583
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Thrombo-embolism in patients with total proconvertin (factor VII) deficency. A report on two cases.

  2009cited by this paper
• Relations between factor VIIa binding and expression of factor VIIa/tissue factor catalytic activity on cell surfaces.

  1992cited by this paper
• Immunohistochemical identification of tissue factor in solid tumors

  1992cited by this paper
• The evaluation of complex-dependent alterations in human factor VIIa.

  1992cited by this paper
• Factor Vlla/Tissue Factor-Catalyzed Activation of Factors IX and X on a Cell Surface and in Suspension: A Kinetic Study

  1992cited by this paper
• The effect of leukocyte elastase on tissue factor pathway inhibitor.

  1992cited by this paper
• Tissue factor pathway inhibitor: the carboxy-terminus is required for optimal inhibition of factor Xa.

  1992cited by this paper
• Factor IXa-factor VIIIa-cell surface complex does not contribute to the basal activation of the coagulation mechanism in vivo.

  1992cited by this paper
• Plasma antigen levels of the lipoprotein-associated coagulation inhibitor in patient samples.

  1991cited by this paper
• The Structural Biology of Expression and Function of Tissue Factor

  1991cited by this paper
• Discordant Expression of Tissue Factor Antigen and Procoagulant Activity on Human Monocytes Activated with LPS and Low Dose Cycloheximide

  1991cited by this paper
• Extrinsic pathway inhibitor--the key to feedback control of blood coagulation initiated by tissue thromboplastin.

  1991cited by this paper
• Factor XI activation in a revised model of blood coagulation

  1991cited by this paper
• Activation of human blood coagulation factor XI independent of factor XII. Factor XI is activated by thrombin and factor XIa in the presence of negatively charged surfaces.

  1991cited by this paper
• Phospholipid-independent and -dependent interactions required for tissue factor receptor and cofactor function.

  1991cited by this paper
• Extrinsic Activation of Human Coagulation Factors IX and X on the Endothelial Surface

  1991cited by this paper
• Initiation of the extrinsic pathway of blood coagulation: evidence for the tissue factor dependent autoactivation of human coagulation factor VII.

  1991cited by this paper
• The coagulation cascade: initiation, maintenance, and regulation.

  1991cited by this paper
• Depletion of extrinsic pathway inhibitor (EPI) sensitizes rabbits to disseminated intravascular coagulation induced with tissue factor: evidence supporting a physiologic role for EPI as a natural anticoagulant.

  1991cited by this paper
• The C-terminus of tissue factor pathway inhibitor is essential to its anticoagulant activity.

  1991cited by this paper
• Immunodepletion of extrinsic pathway inhibitor sensitizes rabbits to endotoxin-induced intravascular coagulation and the generalized Shwartzman reaction.

  1991cited by this paper
• Synthesis, purification, and characterization of an Arg152----Glu site-directed mutant of recombinant human blood clotting factor VII.

  1990cited by this paper
• Proteolytic activation of human factors IX and X by recombinant human factor VIIa: effects of calcium, phospholipids, and tissue factor.

  1990cited by this paper
• Factor IX is activated in vivo by the tissue factor mechanism.

  1990cited by this paper
• Hemophilia as a defect of the tissue factor pathway of blood coagulation: effect of factors VIII and IX on factor X activation in a continuous-flow reactor.

  1990cited by this paper
• Recombinant human extrinsic pathway inhibitor. Production, isolation, and characterization of its inhibitory activity on tissue factor-initiated coagulation reactions.

  1990cited by this paper
• Regulation of coagulation by a multivalent Kunitz-type inhibitor.

  1990cited by this paper
• Cultured normal human hepatocytes do not synthesize lipoprotein-associated coagulation inhibitor: evidence that endothelium is the principal site of its synthesis.

  1990cited by this paper
• Properties of factor VIIa/tissue factor complexes in an umbilical vein model.

  1990cited by this paper
• Factor VIIa-catalyzed activation of factor X independent of tissue factor: its possible significance for control of hemophilic bleeding by infused factor VIIa.

  1990cited by this paper
• Disseminated intravascular coagulation in rabbits induced by administration of endotoxin or tissue factor: effect of anti-tissue factor antibodies and measurement of plasma extrinsic pathway inhibitor activity.

  1990cited by this paper
• The contributions of Ca2+, phospholipids and tissue-factor apoprotein to the activation of human blood-coagulation factor X by activated factor VII.

  1990cited by this paper
• Expression of tissue factor procoagulant activity: regulation by cytosolic calcium.

  1990cited by this paper
• The effect of von Willebrand factor on activation of factor VIII by factor Xa.

  1990cited by this paper
• Functional significance of the Kunitz-type inhibitory domains of lipoprotein-associated coagulation inhibitor

  1989cited by this paper
• Activation of human factor VII by factors IXa and Xa on human bladder carcinoma cells.

  1989cited by this paper
• DETECTION OF FACTOR X ACTIVATION IN HUMANS

  1989cited by this paper
• Inhibition of factor VIIa/tissue factor-induced blood coagulation: with particular emphasis upon a factor Xa-dependent inhibitory mechanism.

  1989cited by this paper
• Purification and characterization of rabbit tissue factor.

  1989cited by this paper
• Human plasma extrinsic pathway inhibitor activity: II. Plasma levels in disseminated intravascular coagulation and hepatocellular disease.

  1989cited by this paper
• Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis.

  1989cited by this paper
• In situ-generated thrombin is the only enzyme that effectively activates factor VIII and factor V in thromboplastin-activated plasma.

  1989cited by this paper
• Studies of the Factor Xa-Dependent Inhibitor of Factor VIIa/Tissue Factor (Extrinsic Pathway Inhibitor) from Cell Supernates of Cultured Human Umbilical Vein Endothelial Cells

  1989cited by this paper
• Autoactivation of human recombinant coagulation factor VII.

  1989cited by this paper
• Zymogen/enzyme discrimination using peptide chloromethyl ketones.

  1989cited by this paper
• Purification and characterization of the lipoprotein-associated coagulation inhibitor from human plasma.

  1989cited by this paper
• Functional tissue factor is entirely cell surface expressed on lipopolysaccharide-stimulated human blood monocytes and a constitutively tissue factor-producing neoplastic cell line

  1989cited by this paper
• Binding of human factors VII and VIIa to a human bladder carcinoma cell line (J82). Implications for the initiation of the extrinsic pathway of blood coagulation.

  1989cited by this paper
• Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque.

  1989cited by this paper
• Functional Properties of Factor VIIa/Tissue Factor Formed with Purified Tissue Factor and with Tissue Factor Expressed on Cultured Endothelial Cells

  1989cited by this paper
• The effect of platelets upon factor Xa-catalyzed activation of factor VII in vitro.

  1988cited by this paper
• Synthesis of thromboplastin (tissue factor) by endothelial cells.

  1988cited by this paper
• The lipoprotein-associated coagulation inhibitor that inhibits the factor VII-tissue factor complex also inhibits factor Xa: insight into its possible mechanism of action.

  1988cited by this paper
• Tissue factor and hemostasis.

  1988cited by this paper
• A comparison of phospholipid and platelets in the activation of human factor VIII by thrombin and factor Xa, and in the activation of factor X.

  1988cited by this paper
• Enhancement by human umbilical vein endothelial cells of factor Xa-catalyzed activation of factor VII.

  1988cited by this paper
• Heparin induces release of extrinsic coagulation pathway inhibitor (EPI).

  1988cited by this paper
• Adhesive receptor Mac-1 coordinates the activation of factor X on stimulated cells of monocytic and myeloid differentiation: an alternative initiation of the coagulation protease cascade.

  1988cited by this paper
• Platelets secrete a coagulation inhibitor functionally and antigenically similar to the lipoprotein associated coagulation inhibitor.

  1988cited by this paper
• Cloning and characterization of a cDNA coding for the lipoprotein-associated coagulation inhibitor shows that it consists of three tandem Kunitz-type inhibitory domains.

  1988cited by this paper
• Initiation of coagulation by tissue factor.

  1988cited by this paper
• Activation of factor VII bound to tissue factor: a key early step in the tissue factor pathway of blood coagulation.

  1988cited by this paper
• Modifications of Extrinsic Pathway Inhibitor (EPI) and Factor Xa that Affect their Ability to Interact and to Inhibit Factor Vila/Tissue Factor: Evidence for a Two-Step Model of Inhibition

  1988cited by this paper
• Molecular cloning of the cDNA for tissue factor, the cellular receptor for the initiation of the coagulation protease cascade.

  1987cited by this paper
• Studies of a mechanism inhibiting the initiation of the extrinsic pathway of coagulation.

  1987cited by this paper
• Initiation of the extrinsic pathway of coagulation. Association of factor VIIa with a cell line expressing tissue factor.

  1987cited by this paper
• Characterization of the inhibition of tissue factor in serum.

  1987cited by this paper
• Partial purification and characterization of extrinsic pathway inhibitor (the factor Xa-dependent plasma inhibitor of factor VIIa/tissue factor).

  1987cited by this paper
• INHIBITOR OF THE FACTOR VIIA-TISSUE FACTOR COMPLEX IS REDUCED IN PATIENTS WITH DISSEMINATED INTRAVASCULAR COAGULATION BUT NOT IN PATIENTS WITH SEVERE HEPATOCELLULAR DISEASE

  1987cited by this paper
• Human tissue factor: cDNA sequence and chromosome localization of the gene.

  1987cited by this paper
• Cloning and expression of human tissue factor cDNA.

  1987cited by this paper
• Isolation of cDNA clones coding for human tissue factor: primary structure of the protein and cDNA.

  1987cited by this paper
• Cooperative interaction between factor VII and cell surface-expressed tissue factor.

  1987cited by this paper
• Activation of human factor VII in the initiation of tissue factor-dependent coagulation.

  1986cited by this paper
• Factor VII binding to tissue factor in reconstituted phospholipid vesicles: induction of cooperativity by phosphatidylserine.

  1986cited by this paper
• Membrane-dependent coagulation reaction is independent of the concentration of phospholipid-bound substrate: fluid phase factor X regulates the extrinsic system.

  1986cited by this paper
• Proteolytic processing of human factor VIII. Correlation of specific cleavages by thrombin, factor Xa, and activated protein C with activation and inactivation of factor VIII coagulant activity.

  1986cited by this paper
• Inhibition of tissue factor/factor VIIa activity in plasma requires factor X and an additional plasma component.

  1985cited by this paper
• Altered factor VII activity in hemophilia.

  1985cited by this paper
• An endothelial cell-dependent pathway of coagulation.

  1985cited by this paper
• Regulation of extravascular coagulation by microvascular permeability.

  1985cited by this paper
• Purification of human brain tissue factor.

  1985cited by this paper
• Tissue factor accelerates the activation of coagulation factor VII: the role of a bifunctional coagulation cofactor.

  1985cited by this paper
• Interleukin 1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells

  1984cited by this paper
• A coagulation pathway on bovine aortic segments leading to generation of Factor Xa and thrombin.

  1984cited by this paper
• Increased tissue thromboplastin activity in monocytes of patients with meningococcal infection: related to an unfavourable prognosis.

  1983cited by this paper
• Cultured human endothelial cells generate tissue factor in response to endotoxin.

  1983cited by this paper
• Factor VII congenital deficiency. Clinical picture and classification of the variants.

  1983cited by this paper
• The dual role of factor VII in blood coagulation. Initiation and inhibition of a proteolytic system by a zymogen.

  1982cited by this paper
• Studies of the prothrombin activation pathway utilizing radioimmunoassays for the F2/F1 + 2 fragment and thrombin--antithrombin complex.

  1982cited by this paper
• An alternative extrinsic pathway of human blood coagulation.

  1982cited by this paper
• Activation of human factor VII by activated factors IX and X.

  1982cited by this paper
• Role of human factor VIII in factor X activation.

  1982cited by this paper
• Interaction Of Factor VIII/Von Willebrand Factor With Phospholipid Vesicles

  1981cited by this paper
• Purification and characterization of bovine tissue factor.

  1981cited by this paper
• Activated factor VII: presence in factor IX concentrates and persistence in the circulation after infusion.

  1979cited by this paper
• Purification and some properties of the protein component of tissue thromboplastin from human brain.

  1977cited by this paper
• Reconstitution and lipid requirements of porcine tissue thromboplastin.

  1977cited by this paper
• Activation of factor IX by the reaction product of tissue factor and factor VII: additional pathway for initiating blood coagulation.

  1977cited by this paper
• The Endotoxin‐induced Coagulant Activity of Human Monocytes

  1975cited by this paper

• Coagulation changes in COVID-19 infection and its implication in management

  2021cites this paper
• Increased microvesicle-associated thrombin generation in patients with immune thrombocytopenia after initiation of thrombopoietin receptor agonists

  2020cites this paper
• Mechanism of Action and Dosage

  2018cites this paper
• Systemic side effects of isolated limb perfusion with tumor necrosis factor alpha

  2018cites this paper
• 9 – Improving the hemocompatibility of biomedical polymers

  2018cites this paper
• Achieving Totally Local Anticoagulation on Blood Contacting Devices

  2018cites this paper
• Pathophysiology of Acute Illness and Injury

  2018cites this paper
• Salivary tissue factor concentration and activity in patients with oral lichen planus

  2017cites this paper
• Nobiletin inhibits oxidized‐LDL mediated expression of Tissue Factor in human endothelial cells through inhibition of NF‐&kgr;B

  2017cites this paper
• The Neisseria meningitidis lpxL1 mutant induces less tissue factor expression and activity in primary human monocytes and monocyte-derived microvesicles than the wild type meningococcus

  2017cites this paper
• The effect of corn trypsin inhibitor, anti-tissue factor pathway inhibitor antibodies and phospholipids on microvesicle-associated thrombin generation in patients with pancreatic cancer and healthy controls

  2017cites this paper
• Coronarography in Patients with Factor XI deficiency: A Literature Review

  2016cites this paper
• Angiogenic Microvascular Endothelial Cells Release Microparticles Rich in Tissue Factor That Promotes Postischemic Collateral Vessel Formation

  2015cites this paper
• blockade on blood coagulation in hypertension -adrenergic stimulation and β Effects of nonspecific

  2015cites this paper
• Local hemostasis, immunothrombosis, and systemic disseminated intravascular coagulation in trauma and traumatic shock

  2015influential citation
• Microparticle-associated tissue factor activity correlates with plasma levels of bacterial lipopolysaccharides in meningococcal septic shock.

  2014cites this paper
• Vascular Endothelium, Influence on Hemostasis: Past and Present

  2014cites this paper
• Inactivation of Factor VIIa by Antithrombin In Vitro, Ex Vivo and In Vivo: Role of Tissue Factor and Endothelial Cell Protein C Receptor

  2014cites this paper
• conformation of factor XIa is essential Model for a factor IX activation complex on blood platelets: dimeric

  2013cites this paper
• The role of the complement system in determining the biocompatibility of candidate materials for medical implantable devices

  2012cites this paper
• Markers of hypercoagulability in CAD patients. Effects of single aspirin and clopidogrel treatment

  2012cites this paper
• Tissue factor: mechanisms of decryption.

  2012cites this paper
• Plasma factor VII: a potential marker of pre-eclampsia.

  2011cites this paper
• Die Stimulierung des Kontaktaktivierungssystems der menschlichen Blutgerinnung durch Lipoprotein-assoziierte Phospholipide

  2011cites this paper
• Nitric Oxide-Generating Silicone As a Blood-Contacting Biomaterial

  2011cites this paper
• Tisssue factor and factor viia cross-species compatibility Tisssue factor and factor viia cross-species compatibility

  2011influential citation
• Plasma tissue factor, tissue factor pathway inhibitor and restenosis following femoropopliteal percutaneous transluminal angioplasty in claudicants

  2011cites this paper
• Nitric oxide therapies for local inhibition of platelets' activitation on blood-contacting surfaces

  2011cites this paper
• Joint protection in haemophilia

  2011cites this paper
• Stable and Vulnerable Atherosclerotic Plaques

  2011cites this paper
• Anticoagulant effects of an antidiabetic drug on monocytes in vitro.

  2011cites this paper
• Heparin-associated anti-Xa activity and platelet-derived prothrombotic and proinflammatory biomarkers in moderate to high-risk patients with acute coronary syndrome

  2011cites this paper
• Establishment of reference intervals for kaolin-activated TEG and the STA compact automated analyzer for dogs and coagulation Response in a canine model of endotoxemia

  2011cites this paper
• Tissue factor and factor VIIa cross-species compatibility.

  2011cites this paper
• Plasminogen activator inhibitor‐1 inhibits factor VIIa bound to tissue factor

  2011cites this paper
• type 2 by human peripheral blood monocytes Thrombin modulates synthesis of plasminogen activator inhibitor

  2011cites this paper
• The role of TFPI in regulation of TF-induced thrombogenicity on the surface of human monocytes.

  2010cites this paper
• Amino acid based enantiomerically pure 3-substituted benzofused heterocycles: A new class of antithrombotic agents.

  2010cites this paper
• Recombinant Activated Factor VII: Mechanisms of Action and Current Indications

  2010cites this paper
• Osteoprotegerin and cardiovascular disease

  2010cites this paper
• Reduced Burst Release of Bioactive rhBMP-2 from a Three-Phase Composite Scaffold

  2010cites this paper
• Sepsis, coagulation and anticoagulants.

  2010cites this paper
• Assessment of endothelial

  2010cites this paper
• Assessment of endothelial dysfunction

  2010cites this paper
• Delivery of TFPI-2 using ultrasound with a microbubble agent (SonoVue) inhibits intimal hyperplasia after balloon injury in a rabbit carotid artery model.

  2010cites this paper
• Expression and purification of recombinant human coagulation Factor VII fused to His-Tag through Gateway technology

  2009cites this paper
• Recombinant Factor VIIa for Bleeding in Non-hemophiliac Pediatric Patients.

  2009cites this paper
• Expression and purification of recombinant human coagulation factor VII fused to a histidine tag using Gateway technology.

  2009cites this paper
• Interrelationship between coagulation factor VII and obesity in diabetes mellitus (type 2).

  2009cites this paper
• Tissue factor antigen is elevated in patients with microvascular complications of diabetes mellitus.

  2009cites this paper
• Effects of structure, morphology and heparin(-like) coatings on the tissue reaction to poly(ethylene terephthalate)

  2009cites this paper
• Thromboelastographic assessment of the efficacy of rFVIIa in vitro and in vivo

  2008cites this paper
• Impact of Adenovirus-mediated Local Expression of Human Tissue Factor Pathway Inhibitor on Vascular Smooth Muscular Cell Proliferation and Apoptosis in the Stent-implanted Femoral Artery of the Rabbit

  2008cites this paper
• Hémostase secondaire ou coagulation plasmatique chez le chien et le chat

  2008cites this paper
• L’endothélium : un nouvel organe

  2008cites this paper
• Clinical guide to the use of antithrombotic drugs in coronary artery disease

  2008cites this paper
• Fundamentals of the thrombosis cascade: interaction between platelets and the coagulation cascade

  2008cites this paper
• Factor VII recombinante activado en cirugía cardíaca, reporte de un caso y revisión de la evidencia científica

  2008cites this paper
• Tissue Factor Pathway Inhibitor: Structure and Function

  2008cites this paper
• Prevention of haemophilic arthropathy during childhood. May common orthopaedic management be extrapolated from patients without inhibitors to patients with inhibitors?

  2008cites this paper
• Factor VIIa and its potential therapeutic use in bleeding-associated pathologies

  2008cites this paper
• ’ endothélium : un nouvel organe he endothelium : A new organ

  2008cites this paper
• Recent advances in clot biology and assessment of clotting

  2008cites this paper
• Clinical and hemostatic responses to treatment in ventilator-associated pneumonia: Role of bacterial pathogens*

  2007cites this paper
• Recombinant factor VIIa (rFVIIa): its potential role as a hemostatic agent

  2007cites this paper
• Modelo celular de la hemostasia y utilidad del factor VII recombinante activado en la práctica clínica

  2007cites this paper
• Coagulation and anticoagulation in acute lung injury, pneumonia, and ventilator-associated lung injury

  2007cites this paper
• The intersubject variability of tissue factor mRNA production in human monocytes--relation with the toll-like receptor 4.

  2007cites this paper
• THE EFFECT OF HAEMOLYSIS ON ANTITHROMBIN CONCENTRATION AS DETERMINED BY A CHROMOGENIC METHOD

  2007cites this paper
• Recombinant factor VIIa: its background, development and clinical use

  2007cites this paper
• All post-translational modifications except propeptide cleavage are required for optimal secretion of coagulation factor VII

  2007cites this paper
• Iron, oxidative stress and early neurological deterioration in ischemic stroke.

  2007cites this paper
• Mechanism of action of factor VIIa in the treatment of coagulopathies.

  2006cites this paper
• Expression des Angiotensin converting enzyme (ACE) bei pulmonaler Hypertonie

  2006cites this paper
• Coagulation interventions in experimental human endotoxemia.

  2006cites this paper
• Indobufen inhibits tissue factor in human monocytes through a thromboxane-mediated mechanism.

  2006cites this paper
• Investigation of tissue factor and other hemostatic profiles in experimental hypothyroidism

  2006cites this paper
• [Microparticles during sepsis and trauma. A link between inflammation and thrombotic processes].

  2006cites this paper
• Mechanism of action, development and clinical experience of recombinant FVIIa.

  2006cites this paper
• Mechanism of Action of Factor VIIa in the Treatment of Coagulopathies

  2006cites this paper
• [Expression of angiotensin I converting enzyme in pulmonary hypertension].

  2006cites this paper
• Mechanism of action of recombinant activated factor VII: an update.

  2006cites this paper
• Successful use of recombinant activated FVII and aminocaproic acid in four neonates with life-threatening hemorrhage

  2006cites this paper
• Microparticules circulantes au cours des traumatismes graves et des sepsis : un élément du couplage inflammation–thrombose

  2006cites this paper
• Flow cytometry-sorted non-viable endotoxin-treated human monocytes are strongly procoagulant

  2006cites this paper
• The use of recombinant factor VIIa (NovoSeven) for treatment of active or impending bleeding in brain injury: broadening the indications.

  2006cites this paper
• Potential role of recombinant factor FVIIa in prophylaxis in severe hemophilia patients with inhibitors

  2006cites this paper
• zum Erwerb des Doktorgrades der Medizin an der Medizinischen Fakultät der Ludwig-Maximilians-Universität zu München

  2006cites this paper
• Estrogenic regulation of tissue factor and tissue factor pathway inhibitor in platelets.

  2005cites this paper
• CXCL16 and CD137 in atherosclerosis

  2005cites this paper
• 2 Between bleeding and thrombosis or beyond

  2005cites this paper
• Discrepancy between tissue factor activity and tissue factor expression in endotoxin-induced monocytes is associated with apoptosis and necrosis

  2005cites this paper
• What causes acute coronary syndromes? Applying Koch's postulates.

  2005cites this paper
• Exosite-mediated Substrate Recognition of Factor IX by Factor XIa

  2005cites this paper
• Recombinant factor VII for severe bleeding during extracorporeal membrane oxygenation following open heart surgery

  2005cites this paper
• Procoagulant phenotype of endothelial cells after coculture with biomaterial-treated blood cells.

  2005cites this paper
• arterial thrombogenecity in rat carotid artery Long-term inhibition of nitric oxide synthesis increases

  2005cites this paper
• Elevated factor VII as a risk factor for recurrent fetal loss

  2005cites this paper
• The endothelium in intensive care.

  2005cites this paper
• Oxidative stress in atherogenesis and arterial thrombosis: the disconnect between cellular studies and clinical outcomes

  2005cites this paper